Table 3 TNM status and stage of OSCC at presentation in relation to gender
Male n (%) | Female n (%) | Total n (%) | |
|---|---|---|---|
T status | |||
T1 | 11 (6.4) | 14 (13.3) | 25 (9.1) |
T2 | 51 (29.8) | 36 (34.3) | 87 (31.4) |
T3 | 48 (28.1) | 21 (20.0) | 69 (25.0) |
T4a | 46 (26.9) | 32 (30.5) | 78 (28.3) |
T4b | 15 (8.8) | 2 (1.9) | 17 (6.2) |
N status | |||
N0 | 91 (53.2) | 70 (66.7) | 161 (58.3) |
N1 | 29 (16.9) | 18 (17.1) | 47 (17.0) |
N2a | 12 (7.1) | 6 (5.7) | 18 (6.5) |
N2b | 32 (18.7) | 9 (8.6) | 41 (14.9) |
N2c | 5 (2.9) | 2 (1.9) | 7 (2.5) |
N3a | 1 (0.6) | 0 (0) | 1 (0.4) |
N3b | 1 (0.6) | 0 (0) | 1 (0.4) |
Stage | |||
I | 11 (6.4) | 10 (9.5) | 21 (7.6) |
II | 38 (22.2) | 27 (25.7) | 65 (23.6) |
III | 42 (24.6) | 28 (26.7) | 70 (25.4) |
IVA | 49 (28.7) | 29 (27.6) | 78 (28.3) |
IVB | 31 (18.1) | 11 (10.5) | 42 (15.1) |